PL3160985T3 - Sposób wytwarzania d-arginylo-2,6-dimetylo-l-tyrozylo-l-lizylo-l-fenyloalaninoamidu - Google Patents

Sposób wytwarzania d-arginylo-2,6-dimetylo-l-tyrozylo-l-lizylo-l-fenyloalaninoamidu

Info

Publication number
PL3160985T3
PL3160985T3 PL15738002T PL15738002T PL3160985T3 PL 3160985 T3 PL3160985 T3 PL 3160985T3 PL 15738002 T PL15738002 T PL 15738002T PL 15738002 T PL15738002 T PL 15738002T PL 3160985 T3 PL3160985 T3 PL 3160985T3
Authority
PL
Poland
Prior art keywords
phenylalaninamide
tyrosyl
arginyl
lysyl
dimethyl
Prior art date
Application number
PL15738002T
Other languages
English (en)
Inventor
Xinjun Zhao
Minyu ZHENG
Xiaozhong YU
Hanrong Gao
Fabrice Cornille
Original Assignee
Flamma S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flamma S.P.A. filed Critical Flamma S.P.A.
Publication of PL3160985T3 publication Critical patent/PL3160985T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL15738002T 2014-06-30 2015-06-24 Sposób wytwarzania d-arginylo-2,6-dimetylo-l-tyrozylo-l-lizylo-l-fenyloalaninoamidu PL3160985T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462019050P 2014-06-30 2014-06-30
PCT/EP2015/064303 WO2016001042A1 (en) 2014-06-30 2015-06-24 Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
EP15738002.3A EP3160985B1 (en) 2014-06-30 2015-06-24 Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide

Publications (1)

Publication Number Publication Date
PL3160985T3 true PL3160985T3 (pl) 2021-12-27

Family

ID=53546577

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15738002T PL3160985T3 (pl) 2014-06-30 2015-06-24 Sposób wytwarzania d-arginylo-2,6-dimetylo-l-tyrozylo-l-lizylo-l-fenyloalaninoamidu

Country Status (8)

Country Link
US (1) US10112976B2 (pl)
EP (1) EP3160985B1 (pl)
JP (1) JP2017523957A (pl)
ES (1) ES2890676T3 (pl)
HU (1) HUE055687T2 (pl)
PL (1) PL3160985T3 (pl)
SI (1) SI3160985T1 (pl)
WO (1) WO2016001042A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE054626T2 (hu) * 2014-06-25 2021-09-28 Flamma Spa Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására
WO2017156403A1 (en) * 2016-03-11 2017-09-14 Stealth Biotherapeutics Crystalline salt forms
CN110087667A (zh) * 2016-08-16 2019-08-02 隐形生物治疗公司 Elamipretide的基于N-羧基酸酐的规模合成
US11034724B2 (en) 2017-04-05 2021-06-15 Stealth Biotherapeutics Corp. Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2
ES2941266T3 (es) * 2018-04-02 2023-05-19 Stealth Biotherapeutics Inc Dipéptidos cristalinos útiles en la síntesis elamipretide
US20230227499A1 (en) * 2020-06-22 2023-07-20 Stealth Biotherapeutics Inc. Prodrugs of mitochondria-targeting oligopeptides
CN117881411A (zh) 2021-06-01 2024-04-12 艾迪雅生物有限责任公司 用于眼部药物的延长释放药物递送系统和使用方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1184317B (it) * 1985-02-05 1987-10-28 Eniricerche Spa Retro-inverso analoghi del peptide potenziatore della bradichina bpp5a
SE9900961D0 (sv) 1999-03-16 1999-03-16 Astra Ab Novel compounds
SI2656854T1 (sl) 2003-02-04 2015-09-30 Cornell Research Foundation, Inc. Uporabe aromatsko-kationskega peptida
EP3167935B1 (en) * 2003-05-01 2018-07-18 Cornell Research Foundation, Inc. Method and carrier complexes for delivering molecules to cells
CA3024434A1 (en) 2004-01-23 2005-08-11 Cornell Research Foundation, Inc. Methods for reducing oxidative damage
FR2871464B1 (fr) * 2004-06-15 2006-09-08 Centre Nat Rech Scient Cnrse Collections de composes tracables et leurs utilisations
WO2007027742A2 (en) * 2005-08-31 2007-03-08 The Trustees Of The University Of Pennsylvania SMALL MOLECULE INTEGRIN α2βl/GPIa-IIa ANTAGONISTS
JP5171613B2 (ja) * 2006-03-01 2013-03-27 株式会社カネカ ペプチドの製造方法
CN107802821A (zh) 2008-02-26 2018-03-16 康奈尔大学 用于防止和治疗急性肾损伤的方法
US20110245182A1 (en) 2010-04-06 2011-10-06 Perricone Nicholas V Topical Uses of Szeto-Schiller Peptides
US20110245183A1 (en) 2010-04-06 2011-10-06 Perricone Nicholas V Topical Uses of Szeto-Schiller Peptides
US20120083452A1 (en) 2010-09-30 2012-04-05 Perricone Nicholas V Topical Anesthetic Uses of Szeto-Schiller Peptides
CA2839408A1 (en) 2011-06-14 2012-12-20 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CA2858550A1 (en) 2011-12-09 2013-06-13 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CA2916492A1 (en) 2013-06-27 2014-12-31 Stealth Biotherapeutics Corp Peptide therapeutics and methods for using same
EP3060573B1 (en) * 2013-10-23 2019-07-17 Kaneka Corporation Tetrapeptide compound and method for producing same
CN106132984B (zh) 2013-12-27 2020-12-08 康德生物医疗技术公司 药学相关的芳香族阳离子肽
HUE054626T2 (hu) * 2014-06-25 2021-09-28 Flamma Spa Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására

Also Published As

Publication number Publication date
SI3160985T1 (sl) 2021-11-30
ES2890676T3 (es) 2022-01-21
US10112976B2 (en) 2018-10-30
HUE055687T2 (hu) 2021-12-28
US20170152289A1 (en) 2017-06-01
WO2016001042A1 (en) 2016-01-07
EP3160985A1 (en) 2017-05-03
EP3160985B1 (en) 2021-07-28
JP2017523957A (ja) 2017-08-24

Similar Documents

Publication Publication Date Title
GB2550003B (en) Process for the production of formaldehyde-stabilised urea
PL3201253T3 (pl) Sposób wytwarzania poliestrów
SG11201701945RA (en) Process for making cyclohexanone
SG11201701764WA (en) Process for making cyclohexanone
SG11201701502VA (en) A process for the production of adenovirus
GB201405800D0 (en) Process
GB201405210D0 (en) Process
SG11201608786YA (en) Method for the production of polyoxazolidinone polymer compounds
SG11201701429SA (en) Process for making cyclohexanone
GB201406890D0 (en) Process
ZA201902125B (en) Process for the production of 2-alkylalkanol
GB201404468D0 (en) Process
GB201413778D0 (en) Methanol production process
SI3160985T1 (sl) Postopek za pripravo D-arginil-2,6-dimetil-L-tirosil-L-lisil-L- fenilalaninamida
GB201402950D0 (en) Process
GB201409126D0 (en) Process
GB201402782D0 (en) Process
GB201400137D0 (en) Process
IL247443B (en) Process for the preparation of 5-fluorotryptophol
PL3182981T3 (pl) Sposób wytwarzania izomaltooligosacharydów
SG11201606954TA (en) Process for the production of modified butyl rubber
HUE054626T2 (hu) Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
PT3362405T (pt) Processo e unidade de produção para a produção de metanol
SG11201704523WA (en) A process for the manufacture of idalopirdine